Kamada (KMDA) Other Operating Expenses (2013 - 2025)
Kamada's (KMDA) quarterly Other Operating Expenses came in at -$1.2 million in Q4 2025, down 145.17% YoY from $2.6 million in Q4 2024, and down 14687.5% on a QoQ basis from -$8000.0 in Q1 2025.
Kamada (KMDA) Other Operating Expenses (2013 - 2025) Analysis & Trends
Kamada (KMDA) has 13 years of Other Operating Expenses data on file, last reported at -$1.2 million in Q4 2025.
- Quarterly Other Operating Expenses fell 145.17% year-over-year to -$1.2 million in Q4 2025, while the trailing twelve-month figure through Mar 2026 was -$1.2 million (down 129.89% YoY) and the FY2025 annual result came in at $2.8 million, down 58.82% from the prior year.
- Other Operating Expenses slipped to -$1.2 million in Q4 2025, from -$8000.0 in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $2.6 million in Q4 2024 to a low of -$2.2 million in Q4 2023.
- A 5-year average of $574300.0 and a median of $1.1 million in 2022 frame the typical range for Other Operating Expenses.
- Annual changes were most pronounced in 2022 — Other Operating Expenses soared 729.41% — and 2023, when it slumped 309.7%.
- Tracing KMDA's Other Operating Expenses over 5 years: stood at $1.4 million in 2021, then declined by 21.29% to $1.1 million in 2022, then tumbled by 309.7% to -$2.2 million in 2023, then jumped by 216.5% to $2.6 million in 2024, then tumbled by 145.17% to -$1.2 million in 2025.
- The last three Other Operating Expenses figures came in at -$1.2 million (Q4 2025), -$8000.0 (Q1 2025), and $2.6 million (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Kamada | 465.93 Mn | 436.45 Mn | 22.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.18 Mn |
| Mar 31, 2025 | -8,000.00 |
| Dec 31, 2024 | 2.62 Mn |
| Sep 30, 2024 | 1.35 Mn |
| Dec 31, 2023 | -2.25 Mn |
| Sep 30, 2023 | 1.07 Mn |
| Dec 31, 2022 | 1.07 Mn |
| Mar 31, 2022 | 2.03 Mn |
| Dec 31, 2021 | 1.36 Mn |
| Mar 31, 2021 | -323,000.00 |
| Dec 31, 2020 | 739,000.00 |
| Sep 30, 2020 | -1,000.00 |
| Mar 31, 2020 | -774,000.00 |
| Dec 31, 2019 | -33,000.00 |
| Sep 30, 2019 | -1,648.00 |
| Jun 30, 2019 | -195.00 |
| Dec 31, 2018 | -70,480.00 |
| Sep 30, 2018 | 70,201.00 |
| Jun 30, 2018 | 4,000.00 |
| Dec 31, 2017 | -122,000.00 |